Literature DB >> 21800036

Major otology day case surgery: viable, cost efficient and safe.

J P O'Neill1, O Young, B Conlon.   

Abstract

BACKGROUND: There has been no study or institution in Ireland promoting major ear surgery performed as a day case procedure in adults. At present, there is a strong political and financial drive for increased elective day case surgery and also a public responsibility to reduce surgical waiting times.
METHODS: A prospective study of 43-day case otology patients who underwent major otological surgeries over an 18-month period in a tertiary referral center. We recorded morbidity, readmission rates and assessed the relationships between procedures performed and complications observed.
RESULTS: We report a same day discharge rate of 88.4% with a next day readmission rate of 2.3%. We report no major morbidities and found no association between the otological procedure performed and complications observed. Furthermore, there was no statistical association between age and complications observed. We have reduced our waiting list from 9 months to 4 weeks over the 18-month period.
CONCLUSION: Major day case otology surgery is an acceptable alternative to an inpatient procedure with favorable discharge rates in comparison to the UK results. Day surgery in this context is safe, cost efficient and expands the surgical possibilities within our department and specialty.

Entities:  

Mesh:

Year:  2011        PMID: 21800036     DOI: 10.1007/s11845-011-0739-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Unexpected overnight admissions following day-case surgery: an analysis of a dedicated ENT day care unit.

Authors:  S Ganesan; A J Prior; J S Rubin
Journal:  Ann R Coll Surg Engl       Date:  2000-09       Impact factor: 1.891

2.  Day-case major ear surgery: is it viable?

Authors:  Abdul A Qureshi; Nigel D Padgham; Dan Jiang
Journal:  J Laryngol Otol       Date:  2005-11-25       Impact factor: 1.469

3.  Factors affecting unanticipated hospital admission following otolaryngologic day surgery.

Authors:  Marc A Tewfik; Saul Frenkiel; Rosa Gasparrini; Anthony Zeitouni; Sam J Daniel; Yalon Dolev; Karen Kost; Mark Samaha; Robert Sweet; Ted L Tewfik
Journal:  J Otolaryngol       Date:  2006-08

4.  Day case myringoplasty using tragal perichondrium.

Authors:  M S Quraishi; N S Jones
Journal:  Clin Otolaryngol Allied Sci       Date:  1995-02

5.  Major ear surgery in a paediatric day care unit.

Authors:  R G Rowlands; R Harris; J Hern; J R Knight
Journal:  J Laryngol Otol       Date:  2002-10       Impact factor: 1.469

6.  A comparative study of patient satisfaction with day case and in-patient major ear surgery.

Authors:  J R Tysome; N D Padgham
Journal:  J Laryngol Otol       Date:  2006-05-23       Impact factor: 1.469

7.  Day-case paediatric mastoid surgery.

Authors:  Richard Gareth Rowlands; Robert Harris; Jonathan David Hern; Jeffrey Robert Knight
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-07       Impact factor: 1.675

  7 in total
  3 in total

1.  The development of one-day surgical care in Hungary between 2010 and 2019.

Authors:  Róbert Pónusz; Dóra Endrei; Dalma Kovács; Evelin Pónusz; Bence Kis Kelemen; Diána Elmer; Noémi Németh; András Vereczkei; Imre Boncz
Journal:  BMC Health Serv Res       Date:  2022-06-20       Impact factor: 2.908

2.  Day-case stapes surgery: Day-case versus inpatient stapes surgery for otosclerosis: a randomized controlled trial.

Authors:  Laura S M Derks; Inge Wegner; Rinze A Tange; Digna M A Kamalski; Wilko Grolman
Journal:  BMC Ear Nose Throat Disord       Date:  2016-02-27

3.  Effect of day-case unilateral cochlear implantation in adults on general and disease-specific quality of life, postoperative complications and hearing results, tinnitus, vertigo and cost-effectiveness: protocol for a randomised controlled trial.

Authors:  Laura S M Derks; Inge Wegner; Adriana L Smit; Hans G X M Thomeer; Vedat Topsakal; Wilko Grolman
Journal:  BMJ Open       Date:  2016-10-03       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.